Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 256

1.

Prevalence, 12-Month Prognosis, and Clinical Management Need of Depression in Coronary Heart Disease Patients: A Prospective Cohort Study.

Kuhlmann SL, Arolt V, Haverkamp W, Martus P, Ströhle A, Waltenberger J, Rieckmann N, Müller-Nordhorn J.

Psychother Psychosom. 2019;88(5):300-311. doi: 10.1159/000501502. Epub 2019 Aug 26.

PMID:
31450228
2.

Common Data Elements for Acute Coronary Syndrome: Analysis Based on the Unified Medical Language System.

Kentgen M, Varghese J, Samol A, Waltenberger J, Dugas M.

JMIR Med Inform. 2019 Aug 23;7(3):e14107. doi: 10.2196/14107.

3.

Characteristics of patients initiated on edoxaban in Europe: baseline data from edoxaban treatment in routine clinical practice for patients with atrial fibrillation (AF) in Europe (ETNA-AF-Europe).

De Caterina R, Kelly P, Monteiro P, Deharo JC, de Asmundis C, López-de-Sá E, Weiss TW, Waltenberger J, Steffel J, de Groot JR, Levy P, Bakhai A, Zierhut W, Laeis P, Kerschnitzki M, Reimitz PE, Kirchhof P; ETNA-AF-Europe investigators.

BMC Cardiovasc Disord. 2019 Jul 12;19(1):165. doi: 10.1186/s12872-019-1144-x.

4.

[Attitudes towards depression and treatment options in patients with coronary heart disease].

Kuhlmann SL, Arolt V, Haverkamp W, Ströhle A, Waltenberger J, Müller-Nordhorn J, Rieckmann N.

Nervenarzt. 2019 Sep;90(9):938-940. doi: 10.1007/s00115-019-0736-0. German. No abstract available.

PMID:
31098651
5.

Unmet medical needs in intermittent Claudication with diabetes and coronary artery disease-A "real-world" analysis on 21 197 PAD patients.

Stalling P, Engelbertz C, Lüders F, Meyborg M, Gebauer K, Waltenberger J, Reinecke H, Freisinger E.

Clin Cardiol. 2019 Jun;42(6):629-636. doi: 10.1002/clc.23186. Epub 2019 May 6.

6.

Five-year results of the BIOFLOW-III Registry: Real-world experience with a biodegradable polymer sirolimus-eluting stent.

Waltenberger J, Brachmann J, van der Heyden J, Richardt G, Fröbert O, Seige M, Friedrich G, Erglis A, Winkens M, Hegeler-Molkewehrum C, Neef M, Hoffmann S; BIOFLOW-III Investigators.

Cardiovasc Revasc Med. 2019 Mar 15. pii: S1553-8389(19)30166-6. doi: 10.1016/j.carrev.2019.03.004. [Epub ahead of print]

PMID:
30922870
7.

Association of Chromosome 9p21 With Subsequent Coronary Heart Disease Events.

Patel RS, Schmidt AF, Tragante V, McCubrey RO, Holmes MV, Howe LJ, Direk K, Åkerblom A, Leander K, Virani SS, Kaminski KA, Muehlschlegel JD, Dubé MP, Allayee H, Almgren P, Alver M, Baranova EV, Behlouli H, Boeckx B, Braund PS, Breitling LP, Delgado G, Duarte NE, Dufresne L, Eriksson N, Foco L, Gijsberts CM, Gong Y, Hartiala J, Heydarpour M, Hubacek JA, Kleber M, Kofink D, Kuukasjärvi P, Lee VV, Leiherer A, Lenzini PA, Levin D, Lyytikäinen LP, Martinelli N, Mons U, Nelson CP, Nikus K, Pilbrow AP, Ploski R, Sun YV, Tanck MWT, Tang WHW, Trompet S, van der Laan SW, van Setten J, Vilmundarson RO, Viviani Anselmi C, Vlachopoulou E, Boerwinkle E, Briguori C, Carlquist JF, Carruthers KF, Casu G, Deanfield J, Deloukas P, Dudbridge F, Fitzpatrick N, Gigante B, James S, Lokki ML, Lotufo PA, Marziliano N, Mordi IR, Muhlestein JB, Newton Cheh C, Pitha J, Saely CH, Samman-Tahhan A, Sandesara PB, Teren A, Timmis A, Van de Werf F, Wauters E, Wilde AAM, Ford I, Stott DJ, Algra A, Andreassi MG, Ardissino D, Arsenault BJ, Ballantyne CM, Bergmeijer TO, Bezzina CR, Body SC, Bogaty P, de Borst GJ, Brenner H, Burkhardt R, Carpeggiani C, Condorelli G, Cooper-DeHoff RM, Cresci S, de Faire U, Doughty RN, Drexel H, Engert JC, Fox KAA, Girelli D, Hagström E, Hazen SL, Held C, Hemingway H, Hoefer IE, Hovingh GK, Johnson JA, de Jong PA, Jukema JW, Kaczor MP, Kähönen M, Kettner J, Kiliszek M, Klungel OH, Lagerqvist B, Lambrechts D, Laurikka JO, Lehtimäki T, Lindholm D, Mahmoodi BK, Maitland-van der Zee AH, McPherson R, Melander O, Metspalu A, Pepinski W, Olivieri O, Opolski G, Palmer CN, Pasterkamp G, Pepine CJ, Pereira AC, Pilote L, Quyyumi AA, Richards AM, Sanak M, Scholz M, Siegbahn A, Sinisalo J, Smith JG, Spertus JA, Stewart AFR, Szczeklik W, Szpakowicz A, Ten Berg JM, Thanassoulis G, Thiery J, van der Graaf Y, Visseren FLJ, Waltenberger J; CARDIoGRAMPlusC4D Consortium, Van der Harst P, Tardif JC, Sattar N, Lang CC, Pare G, Brophy JM, Anderson JL, März W, Wallentin L, Cameron VA, Horne BD, Samani NJ, Hingorani AD, Asselbergs FW.

Circ Genom Precis Med. 2019 Apr;12(4):e002471. doi: 10.1161/CIRCGEN.119.002471. Epub 2019 Mar 21.

PMID:
30897348
8.

Subsequent Event Risk in Individuals With Established Coronary Heart Disease.

Patel RS, Tragante V, Schmidt AF, McCubrey RO, Holmes MV, Howe LJ, Direk K, Åkerblom A, Leander K, Virani SS, Kaminski KA, Muehlschlegel JD, Allayee H, Almgren P, Alver M, Baranova EV, Behloui H, Boeckx B, Braund PS, Breitling LP, Delgado G, Duarte NE, Dubé MP, Dufresne L, Eriksson N, Foco L, Scholz M, Gijsberts CM, Glinge C, Gong Y, Hartiala J, Heydarpour M, Hubacek JA, Kleber M, Kofink D, Kotti S, Kuukasjärvi P, Lee VV, Leiherer A, Lenzini PA, Levin D, Lyytikäinen LP, Martinelli N, Mons U, Nelson CP, Nikus K, Pilbrow AP, Ploski R, Sun YV, Tanck MWT, Tang WHW, Trompet S, van der Laan SW, Van Setten J, Vilmundarson RO, Viviani Anselmi C, Vlachopoulou E, Al Ali L, Boerwinkle E, Briguori C, Carlquist JF, Carruthers KF, Casu G, Deanfield J, Deloukas P, Dudbridge F, Engstrøm T, Fitzpatrick N, Fox K, Gigante B, James S, Lokki ML, Lotufo PA, Marziliano N, Mordi IR, Muhlestein JB, Newton-Cheh C, Pitha J, Saely CH, Samman-Tahhan A, Sandesara PB, Teren A, Timmis A, Van de Werf F, Wauters E, Wilde AAM, Ford I, Stott DJ, Algra A, Andreassi MG, Ardissino D, Arsenault BJ, Ballantyne CM, Bergmeijer TO, Bezzina CR, Body SC, Boersma EH, Bogaty P, Bots ML, Brenner H, Brugts JJ, Burkhardt R, Carpeggiani C, Condorelli G, Cooper-DeHoff RM, Cresci S, Danchin N, de Faire U, Doughty RN, Drexel H, Engert JC, Fox KAA, Girelli D, Grobbee DE, Hagström E, Hazen SL, Held C, Hemingway H, Hoefer IE, Hovingh GK, Jabbari R, Johnson JA, Jukema JW, Kaczor MP, Kähönen M, Kettner J, Kiliszek M, Klungel OH, Lagerqvist B, Lambrechts D, Laurikka JO, Lehtimäki T, Lindholm D, Mahmoodi BK, Maitland-van der Zee AH, McPherson R, Melander O, Metspalu A, Niemcunowicz-Janica A, Olivieri O, Opolski G, Palmer CN, Pasterkamp G, Pepine CJ, Pereira AC, Pilote L, Quyyumi AA, Richards AM, Sanak M, Siegbahn A, Simon T, Sinisalo J, Smith JG, Spertus JA, Stender S, Stewart AFR, Szczeklik W, Szpakowicz A, Tardif JC, Ten Berg JM, Tfelt-Hansen J, Thanassoulis G, Thiery J, Torp-Pedersen C, van der Graaf Y, Visseren FLJ, Waltenberger J, Weeke PE, Van der Harst P, Lang CC, Sattar N, Cameron VA, Anderson JL, Brophy JM, Pare G, Horne BD, März W, Wallentin L, Samani NJ, Hingorani AD, Asselbergs FW.

Circ Genom Precis Med. 2019 Apr;12(4):e002470. doi: 10.1161/CIRCGEN.119.002470. Epub 2019 Mar 21.

PMID:
30896328
9.

Mechanisms of Trained Innate Immunity in oxLDL Primed Human Coronary Smooth Muscle Cells.

Schnack L, Sohrabi Y, Lagache SMM, Kahles F, Bruemmer D, Waltenberger J, Findeisen HM.

Front Immunol. 2019 Jan 23;10:13. doi: 10.3389/fimmu.2019.00013. eCollection 2019.

10.

mTOR-Dependent Oxidative Stress Regulates oxLDL-Induced Trained Innate Immunity in Human Monocytes.

Sohrabi Y, Lagache SMM, Schnack L, Godfrey R, Kahles F, Bruemmer D, Waltenberger J, Findeisen HM.

Front Immunol. 2019 Jan 22;9:3155. doi: 10.3389/fimmu.2018.03155. eCollection 2018.

11.

Depressive symptoms and health care within 30 days after discharge from a cardiac hospital unit: Response letter to the editor.

Hornung J, Kuhlmann SL, Radzimanowski M, Jörgens S, Haverkamp W, Martus P, Ströhle A, Waltenberger J, Arolt V, Müller-Nordhorn J, Rieckmann N.

Gen Hosp Psychiatry. 2019 Jan 24. pii: S0163-8343(19)30030-1. doi: 10.1016/j.genhosppsych.2019.01.006. [Epub ahead of print] No abstract available.

PMID:
30712926
12.

Design and rationale of the Edoxaban Treatment in routiNe clinical prActice for patients with Atrial Fibrillation in Europe (ETNA-AF-Europe) study.

De Caterina R, Kelly P, Monteiro P, Deharo JC, de Asmundis C, López-de-Sá E, Weiss TW, Waltenberger J, Steffel J, de Groot JR, Levy P, Bakhai A, Zierhut W, Laeis P, Reimitz PE, Kirchhof P; ETNA-AF-Europe investigators.

J Cardiovasc Med (Hagerstown). 2019 Feb;20(2):97-104. doi: 10.2459/JCM.0000000000000737.

PMID:
30540648
13.

Depressive symptoms and health care within 30 days after discharge from a cardiac hospital unit.

Hornung J, Kuhlmann SL, Radzimanowski M, Jörgens S, Haverkamp W, Martus P, Ströhle A, Waltenberger J, Arolt V, Müller-Nordhorn J, Rieckmann N.

Gen Hosp Psychiatry. 2019 Jan - Feb;56:19-27. doi: 10.1016/j.genhosppsych.2018.10.001. Epub 2018 Oct 6.

PMID:
30530266
14.
15.

Hyperglycaemia-induced methylglyoxal accumulation potentiates VEGF resistance of diabetic monocytes through the aberrant activation of tyrosine phosphatase SHP-2/SRC kinase signalling axis.

Dorenkamp M, Müller JP, Shanmuganathan KS, Schulten H, Müller N, Löffler I, Müller UA, Wolf G, Böhmer FD, Godfrey R, Waltenberger J.

Sci Rep. 2018 Oct 2;8(1):14684. doi: 10.1038/s41598-018-33014-9.

16.

Light-enhanced VEGF121/rGel: A tumor targeted modality with vascular and immune-mediated efficacy.

Weyergang A, Fremstedal AS, Skarpen E, Peng Q, Mohamedali KA, Eng MS, Cheung LH, Rosenblum MG, Waltenberger J, Berg K.

J Control Release. 2018 Oct 28;288:161-172. doi: 10.1016/j.jconrel.2018.09.005. Epub 2018 Sep 11.

PMID:
30217739
17.

BMP-2 induces human mononuclear cell chemotaxis and adhesion and modulates monocyte-to-macrophage differentiation.

Pardali E, Makowski LM, Leffers M, Borgscheiper A, Waltenberger J.

J Cell Mol Med. 2018 Nov;22(11):5429-5438. doi: 10.1111/jcmm.13814. Epub 2018 Aug 13.

18.

Scientists on the Spot: The past, present, and future of the Council on Basic Cardiovascular Science.

Waltenberger J, Pearson J.

Cardiovasc Res. 2018 Aug 1;114(10):e74-e75. doi: 10.1093/cvr/cvy178. No abstract available.

PMID:
30052923
19.

Molecular and cellular insights into the pathogenesis of coronary artery ectasia.

Ozturk S, Yetkin E, Waltenberger J.

Cardiovasc Pathol. 2018 Jul - Aug;35:37-47. doi: 10.1016/j.carpath.2018.04.005. Epub 2018 Apr 16. Review.

PMID:
29772448
20.

Consensus guidelines for the use and interpretation of angiogenesis assays.

Nowak-Sliwinska P, Alitalo K, Allen E, Anisimov A, Aplin AC, Auerbach R, Augustin HG, Bates DO, van Beijnum JR, Bender RHF, Bergers G, Bikfalvi A, Bischoff J, Böck BC, Brooks PC, Bussolino F, Cakir B, Carmeliet P, Castranova D, Cimpean AM, Cleaver O, Coukos G, Davis GE, De Palma M, Dimberg A, Dings RPM, Djonov V, Dudley AC, Dufton NP, Fendt SM, Ferrara N, Fruttiger M, Fukumura D, Ghesquière B, Gong Y, Griffin RJ, Harris AL, Hughes CCW, Hultgren NW, Iruela-Arispe ML, Irving M, Jain RK, Kalluri R, Kalucka J, Kerbel RS, Kitajewski J, Klaassen I, Kleinmann HK, Koolwijk P, Kuczynski E, Kwak BR, Marien K, Melero-Martin JM, Munn LL, Nicosia RF, Noel A, Nurro J, Olsson AK, Petrova TV, Pietras K, Pili R, Pollard JW, Post MJ, Quax PHA, Rabinovich GA, Raica M, Randi AM, Ribatti D, Ruegg C, Schlingemann RO, Schulte-Merker S, Smith LEH, Song JW, Stacker SA, Stalin J, Stratman AN, Van de Velde M, van Hinsbergh VWM, Vermeulen PB, Waltenberger J, Weinstein BM, Xin H, Yetkin-Arik B, Yla-Herttuala S, Yoder MC, Griffioen AW.

Angiogenesis. 2018 Aug;21(3):425-532. doi: 10.1007/s10456-018-9613-x. Review.

21.

Ecchymosis: A novel sign in patients with varicose veins.

Yetkin E, Ileri M, Waltenberger J.

Clin Hemorheol Microcirc. 2018;68(4):413-419. doi: 10.3233/CH-170320.

PMID:
29660929
22.

Reversibility of platelet P2Y12 inhibition by platelet supplementation: ex vivo and in vitro comparisons of prasugrel, clopidogrel and ticagrelor.

Bertling A, Fender AC, Schüngel L, Rumpf M, Mergemeier K, Geißler G, Sibrowski W, Kelsch R, Waltenberger J, Jakubowski JA, Kehrel BE.

J Thromb Haemost. 2018 Jun;16(6):1089-1098. doi: 10.1111/jth.14014. Epub 2018 Apr 23.

PMID:
29582544
23.

Low density lipoprotein interferes with intracellular signaling of monocytes resulting in impaired chemotaxis and enhanced chemokinesis.

Tjaden K, Adam C, Godfrey R, Hanley PJ, Pardali E, Waltenberger J.

Int J Cardiol. 2018 Mar 15;255:160-165. doi: 10.1016/j.ijcard.2017.11.109.

PMID:
29425557
24.

Cardiac computed tomography in patients with symptomatic new-onset atrial fibrillation, rule-out acute coronary syndrome, but with intermediate pretest probability for coronary artery disease admitted to a chest pain unit.

Koopmann M, Hinrichs L, Olligs J, Lichtenberg M, Eckardt L, Böse D, Möhlenkamp S, Waltenberger J, Breuckmann F.

Eur J Med Res. 2018 Jan 24;23(1):6. doi: 10.1186/s40001-018-0303-3.

25.

Correction: Patients with Acute Myeloid Leukemia Admitted to Intensive Care Units: Outcome Analysis and Risk Prediction.

Pohlen M, Thoennissen NH, Braess J, Thudium J, Schmid C, Kochanek M, Kreuzer KA, Lebiedz P, Görlich D, Gerth HU, Rohde C, Kessler T, Müller-Tidow C, Stelljes M, Hullerman C, Büchner T, Schlimok G, Hallek M, Waltenberger J, Hiddemann W, Berdel WE, Heilmeier B, Krug U.

PLoS One. 2018 Jan 2;13(1):e0190802. doi: 10.1371/journal.pone.0190802. eCollection 2018.

26.

Monocyte gene expression in childhood obesity is associated with obesity and complexity of atherosclerosis in adults.

Keustermans GC, Kofink D, Eikendal A, de Jager W, Meerding J, Nuboer R, Waltenberger J, Kraaijeveld AO, Jukema JW, Sels JW, Garssen J, Prakken BJ, Asselbergs FW, Kalkhoven E, Hoefer IE, Pasterkamp G, Schipper HS.

Sci Rep. 2017 Dec 4;7(1):16826. doi: 10.1038/s41598-017-17195-3.

27.

Chronic refractory angina pectoris: recent progress and remaining challenges.

Waltenberger J.

Eur Heart J. 2017 Sep 1;38(33):2556-2558. doi: 10.1093/eurheartj/ehx421. No abstract available. Erratum in: Eur Heart J. 2018 May 14;39(19):1697.

28.

Optimal duration of dual antiplatelet therapy after percutaneous coronary intervention or after acute coronary syndrome : Practical lessons from a review.

Ten Berg JM, Zwart B, van 't Hof AWJ, Liem A, Waltenberger J, de Winter RJ, Jukema JW.

Neth Heart J. 2017 Dec;25(12):655-663. doi: 10.1007/s12471-017-1023-y. Review.

29.

Hyaluronan/Collagen Hydrogels with Sulfated Hyaluronan for Improved Repair of Vascularized Tissue Tune the Binding of Proteins and Promote Endothelial Cell Growth.

Rother S, Galiazzo VD, Kilian D, Fiebig KM, Becher J, Moeller S, Hempel U, Schnabelrauch M, Waltenberger J, Scharnweber D, Hintze V.

Macromol Biosci. 2017 Nov;17(11). doi: 10.1002/mabi.201700154. Epub 2017 Jul 6.

PMID:
28683182
30.

Hh signaling in regeneration of the ischemic heart.

Dunaeva M, Waltenberger J.

Cell Mol Life Sci. 2017 Oct;74(19):3481-3490. doi: 10.1007/s00018-017-2534-9. Epub 2017 May 18. Review.

31.

Intracoronary autologous bone marrow cell transfer after myocardial infarction: the BOOST-2 randomised placebo-controlled clinical trial.

Wollert KC, Meyer GP, Müller-Ehmsen J, Tschöpe C, Bonarjee V, Larsen AI, May AE, Empen K, Chorianopoulos E, Tebbe U, Waltenberger J, Mahrholdt H, Ritter B, Pirr J, Fischer D, Korf-Klingebiel M, Arseniev L, Heuft HG, Brinchmann JE, Messinger D, Hertenstein B, Ganser A, Katus HA, Felix SB, Gawaz MP, Dickstein K, Schultheiss HP, Ladage D, Greulich S, Bauersachs J.

Eur Heart J. 2017 Oct 14;38(39):2936-2943. doi: 10.1093/eurheartj/ehx188.

PMID:
28431003
32.

[Diagnostic Accuracy of German Depression Screenings in Patients with Coronary Heart Disease].

Tschorn M, Rieckmann N, Arolt V, Beer K, Haverkamp W, Martus P, Waltenberger J, Müller-Nordhorn J, Ströhle A.

Psychiatr Prax. 2019 Jan;46(1):41-48. doi: 10.1055/s-0042-123434. Epub 2017 Apr 3. German.

PMID:
28371958
33.

Diagnostic value of global myocardial perfusion reserve assessment based on coronary sinus flow measurements using cardiovascular magnetic resonance in addition to myocardial stress perfusion imaging.

Shomanova Z, Florian A, Bietenbeck M, Waltenberger J, Sechtem U, Yilmaz A.

Eur Heart J Cardiovasc Imaging. 2017 May 1;18(8):851-859. doi: 10.1093/ehjci/jew315.

PMID:
28369259
34.

Direct detection of nano-scale extracellular vesicles derived from inflammation-triggered endothelial cells using surface plasmon resonance.

Hosseinkhani B, van den Akker N, D'Haen J, Gagliardi M, Struys T, Lambrichts I, Waltenberger J, Nelissen I, Hooyberghs J, Molin DGM, Michiels L.

Nanomedicine. 2017 Jul;13(5):1663-1671. doi: 10.1016/j.nano.2017.03.010. Epub 2017 Mar 30.

35.

Additional Candidate Genes for Human Atherosclerotic Disease Identified Through Annotation Based on Chromatin Organization.

Haitjema S, Meddens CA, van der Laan SW, Kofink D, Harakalova M, Tragante V, Foroughi Asl H, van Setten J, Brandt MM, Bis JC, O'Donnell C, Cheng C, Hoefer IE, Waltenberger J, Biessen E, Jukema JW, Doevendans PA, Nieuwenhuis EE, Erdmann J, Björkegren JL, Pasterkamp G, Asselbergs FW, den Ruijter HM, Mokry M.

Circ Cardiovasc Genet. 2017 Apr;10(2). pii: e001664. doi: 10.1161/CIRCGENETICS.116.001664.

PMID:
28320757
36.

Serum brain-derived neurotrophic factor and depressive symptoms in coronary heart disease patients: Role of cognitive functions.

Kuhlmann SL, Tschorn M, Arolt V, Beer K, Brandt J, Grosse L, Haverkamp W, Müller-Nordhorn J, Rieckmann N, Waltenberger J, Warnke K, Hellweg R, Ströhle A.

Psychoneuroendocrinology. 2017 May;79:175-176. doi: 10.1016/j.psyneuen.2017.02.010. Epub 2017 Mar 1. No abstract available.

PMID:
28292627
37.

Sulfated Hyaluronan Alters Endothelial Cell Activation in Vitro by Controlling the Biological Activity of the Angiogenic Factors Vascular Endothelial Growth Factor-A and Tissue Inhibitor of Metalloproteinase-3.

Rother S, Samsonov SA, Moeller S, Schnabelrauch M, Rademann J, Blaszkiewicz J, Köhling S, Waltenberger J, Pisabarro MT, Scharnweber D, Hintze V.

ACS Appl Mater Interfaces. 2017 Mar 22;9(11):9539-9550. doi: 10.1021/acsami.7b01300. Epub 2017 Mar 13.

PMID:
28248081
38.

Serum brain-derived neurotrophic factor and stability of depressive symptoms in coronary heart disease patients: A prospective study.

Kuhlmann SL, Tschorn M, Arolt V, Beer K, Brandt J, Grosse L, Haverkamp W, Müller-Nordhorn J, Rieckmann N, Waltenberger J, Warnke K, Hellweg R, Ströhle A.

Psychoneuroendocrinology. 2017 Mar;77:196-202. doi: 10.1016/j.psyneuen.2016.12.015. Epub 2016 Dec 23.

PMID:
28092760
39.
40.

Incidence of left atrial abnormalities under treatment with dabigatran, rivaroxaban, and vitamin K antagonists.

Reers S, Agdirlioglu T, Kellner M, Borowski M, Thiele H, Waltenberger J, Reppel M.

Eur J Med Res. 2016 Oct 21;21(1):41.

41.

Leptin-induced transphosphorylation of vascular endothelial growth factor receptor increases Notch and stimulates endothelial cell angiogenic transformation.

Lanier V, Gillespie C, Leffers M, Daley-Brown D, Milner J, Lipsey C, Webb N, Anderson LM, Newman G, Waltenberger J, Gonzalez-Perez RR.

Int J Biochem Cell Biol. 2016 Oct;79:139-150. doi: 10.1016/j.biocel.2016.08.023. Epub 2016 Aug 30.

42.

Patients with Acute Myeloid Leukemia Admitted to Intensive Care Units: Outcome Analysis and Risk Prediction.

Pohlen M, Thoennissen NH, Braess J, Thudium J, Schmid C, Kochanek M, Kreuzer KA, Lebiedz P, Görlich D, Gerth HU, Rohde C, Kessler T, Müller-Tidow C, Stelljes M, Hullermann C, Büchner T, Schlimok G, Hallek M, Waltenberger J, Hiddemann W, Berdel WE, Heilmeier B, Krug U.

PLoS One. 2016 Aug 30;11(8):e0160871. doi: 10.1371/journal.pone.0160871. eCollection 2016. Erratum in: PLoS One. 2018 Jan 2;13(1):e0190802.

43.

Improved Clinical Risk Stratification in Patients with Long QT Syndrome? Novel Insights from Multi-Channel ECGs.

Samol A, Gönes M, Zumhagen S, Bruns HJ, Paul M, Vahlhaus C, Waltenberger J, Schulze-Bahr E, Eckardt L, Mönnig G.

PLoS One. 2016 Jul 5;11(7):e0158085. doi: 10.1371/journal.pone.0158085. eCollection 2016.

44.

On- versus off-hour care for patients with non-ST-segment elevation myocardial infarction in Germany : Exemplary results within the chest pain unit concept.

Breuckmann F, Remberg F, Böse D, Waltenberger J, Fischer D, Rassaf T.

Herz. 2016 Dec;41(8):725-731. Epub 2016 May 19.

PMID:
27193907
45.

Identification of cardiomyopathy associated circulating miRNA biomarkers in patients with muscular dystrophy using a complementary cardiovascular magnetic resonance and plasma profiling approach.

Becker S, Florian A, Patrascu A, Rösch S, Waltenberger J, Sechtem U, Schwab M, Schaeffeler E, Yilmaz A.

J Cardiovasc Magn Reson. 2016 May 6;18(1):25. doi: 10.1186/s12968-016-0244-3.

46.

Coronary Artery Calcium as an Independent Surrogate Marker in the Risk Assessment of Patients With Atrial Fibrillation and an Intermediate Pretest Likelihood for Coronary Artery Disease Admitted to a German Chest Pain Unit.

Breuckmann F, Olligs J, Hinrichs L, Koopmann M, Lichtenberg M, Böse D, Fischer D, Eckardt L, Waltenberger J, Garvey JL.

Clin Cardiol. 2016 Mar;39(3):157-64. doi: 10.1002/clc.22506.

47.

How rapid is rapid? Exemplary results of real-life rapid rule-out troponin timing in troponin-positive acute coronary syndromes without persistent ST-segment elevation in two contrasting German chest pain unit facilities.

Fischer D, Remberg F, Böse D, Lichtenberg M, Kümpers P, Lebiedz P, Pavenstädt HJ, Waltenberger J, Breuckmann F.

Eur J Med Res. 2016 Mar 17;21:11. doi: 10.1186/s40001-016-0206-0.

48.

Cardiac shockwave therapy in patients with chronic refractory angina pectoris.

Vainer J, Habets JH, Schalla S, Lousberg AH, de Pont CD, Vöö SA, Brans BT, Hoorntje JC, Waltenberger J.

Neth Heart J. 2016 May;24(5):343-9. doi: 10.1007/s12471-016-0821-y.

49.

Randomized Control of Sympathetic Drive With Continuous Intravenous Esmolol in Patients With Acute ST-Segment Elevation Myocardial Infarction: The BEtA-Blocker Therapy in Acute Myocardial Infarction (BEAT-AMI) Trial.

Er F, Dahlem KM, Nia AM, Erdmann E, Waltenberger J, Hellmich M, Kuhr K, Le MT, Herrfurth T, Taghiyev Z, Biesenbach E, Yüksel D, Eran-Ergöknil A, Vanezi M, Caglayan E, Gassanov N.

JACC Cardiovasc Interv. 2016 Feb 8;9(3):231-240. doi: 10.1016/j.jcin.2015.10.035.

50.

Treatment variation in stent choice in patients with stable or unstable coronary artery disease.

Burgers LT, McClellan EA, Hoefer IE, Pasterkamp G, Jukema JW, Horsman S, Pijls NH, Waltenberger J, Hillaert MA, Stubbs AC, Severens JL, Redekop WK.

Neth Heart J. 2016 Feb;24(2):110-9. doi: 10.1007/s12471-015-0783-5.

Supplemental Content

Loading ...
Support Center